BioCentury
ARTICLE | Financial News

Jan. 9 Financial Quick Takes: Closes for two royalty funds; plus Apellis leads follow-on trio, Element, Omniome, Hinova, Emergex, Tscan, Calliditas

January 10, 2020 12:50 AM UTC
Updated on Jan 10, 2020 at 1:30 AM UTC

HealthCare Royalty, Sagard close royalty funds
HealthCare Royalty Partners closed its HealthCare Royalty Partners IV fund at $1.8 billion. The firm also promoted four team members to managing director: Carlos Almodóvar, head of IR; Shin Kang, head of research; Andrew Reardon, chief legal officer; and Spencer Schneider, chief compliance officer and IP counsel.

Sagard Holdings said it raised $475 million in the first close of its Sagard Healthcare Royalty Partners fund, which will make royalty investments tied to biopharma products and medical devices and offer non-dilutive financing solutions to commercial-stage biopharmas. ...